LMR Partners’s Pediatrix Medical MD Stock Holding History

LMR Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-102,172	Closed	-$5.46M	–	551
2018 Q1	$5.46M	Hold	102,172	–	–	0.56%	27
2017 Q4	$5.46M	Buy	+102,172	New	+$4.82M	0.56%	27
2015 Q4	–	Sell	-109,896	Closed	-$8.44M	–	309
2015 Q3	$8.44M	Buy	+109,896	New	+$8.87M	0.92%	25
2015 Q2	–	Sell	-68,536	Closed	-$4.97M	–	581
2015 Q1	$4.97M	Buy	+68,536	New	+$4.76M	0.69%	46

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LMR Partners's MD Position: Q2 2018 in Review

LMR Partners sold out of Pediatrix Medical (MD) in Q2 2018, closing a stake of 102,172 shares — an estimated $5.46M sold.

LMR Partners first reported a position in MD in Q1 2015 and held it in 4 quarters. The position peaked at $8.44M in Q3 2015. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

LMR Partners reported no remaining Pediatrix Medical position as of Q2 2018 after selling out during the quarter.
LMR Partners sold 102,172 Pediatrix Medical shares in Q2 2018, an estimated $5.46M.
LMR Partners first reported a position in Pediatrix Medical in Q1 2015 and held it in 4 quarters.
LMR Partners's Pediatrix Medical position peaked at $8.44M in Q3 2015.
322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on LMR Partners's 13F filing for Q2 2018, filed 3 Aug 2018.